Immune-cell block halts brain tumour
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Access through your institution Buy or subscribe A drug that targets the white blood cells fostering brain tumours — rather than the cancer cells themselves — shrinks tumours in mice. The
aggressive brain cancer known as glioblastoma is notoriously difficult to treat. Johanna Joyce at the Memorial Sloan-Kettering Cancer Center in New York and her colleagues gave mice with
glioblastomas a drug that inhibits a cell-surface protein called colony-stimulating factor-1 receptor. This protein is expressed mainly on the white blood cells, or macrophages, that
surround the tumour. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues
and online access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local
taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support RIGHTS AND PERMISSIONS
Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Immune-cell block halts brain tumour. _Nature_ 502, 274 (2013). https://doi.org/10.1038/502274b Download citation * Published:
16 October 2013 * Issue Date: 17 October 2013 * DOI: https://doi.org/10.1038/502274b SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get
shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative